Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03044132 · ClinicalTrials.gov registry record · NA
DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers
A NA study, sponsored by LifeNet Health.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03044132 is a NA study that has completed, run by LifeNet Health. The registered enrollment target is 61 participants.
The verdict
NCT03044132, a NA study, has completed, sponsored by LifeNet Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, clinical research trial evaluating the clinical outcomes of DermACELL AWM in dermal regeneration.
Interventions
- OTHER DermACELL AWM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2017-01-15 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03044132
The ClinicalTrials.gov registry entry for NCT03044132 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeNet Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DermACELL AWM is the first listed.
NCT03044132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03044132 about?
NCT03044132 is a clinical study titled "DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers". This is a prospective, multicenter, clinical research trial evaluating the clinical outcomes of DermACELL AWM in dermal regeneration.
What is the current status of trial NCT03044132?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2017-01-15. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03044132?
The interventions under investigation include: DermACELL AWM (OTHER).
Who is sponsoring clinical trial NCT03044132?
This trial is sponsored by LifeNet Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.